Neutrons for neurons and cyclotrons for radioisotopes (Spanish Edition)

Glioblastoma is an aggressive malignancy and accounts for about 15 per cent of all brain tumours. Even when initially controlled by treatment, the cancer almost always returns. Surgery and radiotherapy can extend survival by some months, but the brain cancer usually ends life within one to two years of diagnosis, and less than five per cent of people survive longer than five years. As with glioblastoma, many cranial cancers, are a challenge to treat due to the sensitive nature of normal brain tissue to surgery and radiotherapy, but there is hope that could change soon, thanks in part to new therapies made possible by accelerators producing intense sources of neutrons.